This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Kisqali
  • /
  • Adjuvant Ribociclib With Endocrine Therapy in Horm...
Clinical trial

Adjuvant Ribociclib With Endocrine Therapy in Hormone Receptor+/HER2- High Risk Early Breast Cancer (EarLEE-1)

Read time: 3 mins
Last updated:19th Jun 2017
Identifier: NCT03078751
Register now for full access to medthority.com